Literature DB >> 29147623

Tissue-resident memory T cells play a key role in the efficacy of cancer vaccines.

C Granier1, C Blanc1, S Karaki1, T Tran1, H Roussel1, E Tartour1,2,3.   

Abstract

Resident memory CD8+T cells (TRM) usually defined by the CD103 marker represent a new subset of long-lived memory T cells that remain in the tissues. We directly demonstrate their specific role in cancer vaccine-induced tumor regression. In human, they also seem to play a major role in tumor immunosurveillance.

Entities:  

Keywords:  cancer vaccine; immunosurveillance; resident memory T cell; route of immunization; tumor microenvironment

Year:  2017        PMID： 29147623      PMCID： PMC5674949          DOI： 10.1080/2162402X.2017.1358841

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells.

Authors:  Pleun Hombrink; Christina Helbig; Ronald A Backer; Berber Piet; Anna E Oja; Regina Stark; Giso Brasser; Aldo Jongejan; René E Jonkers; Benjamin Nota; Onur Basak; Hans C Clevers; Perry D Moerland; Derk Amsen; René A W van Lier
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

2.  Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes.

Authors:  Laura K Mackay; Martina Minnich; Natasja A M Kragten; Yang Liao; Benjamin Nota; Cyril Seillet; Ali Zaid; Kevin Man; Simon Preston; David Freestone; Asolina Braun; Erica Wynne-Jones; Felix M Behr; Regina Stark; Daniel G Pellicci; Dale I Godfrey; Gabrielle T Belz; Marc Pellegrini; Thomas Gebhardt; Meinrad Busslinger; Wei Shi; Francis R Carbone; René A W van Lier; Axel Kallies; Klaas P J M van Gisbergen
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

3.  Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.

Authors:  Anusha-Preethi Ganesan; James Clarke; Oliver Wood; Eva M Garrido-Martin; Serena J Chee; Toby Mellows; Daniela Samaniego-Castruita; Divya Singh; Grégory Seumois; Aiman Alzetani; Edwin Woo; Peter S Friedmann; Emma V King; Gareth J Thomas; Tilman Sanchez-Elsner; Pandurangan Vijayanand; Christian H Ottensmeier
Journal:  Nat Immunol       Date:  2017-06-19       Impact factor: 25.606

4.  Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.

Authors:  Yun-Yan Sun; Shiwen Peng; Liping Han; Jin Qiu; Liwen Song; Yachea Tsai; Benjamin Yang; Richard B S Roden; Cornelia L Trimble; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2015-09-29       Impact factor: 12.531

5.  Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.

Authors:  Te-Chia Wu; Kangling Xu; Romain Banchereau; Florentina Marches; Chun I Yu; Jan Martinek; Esperanza Anguiano; Alexander Pedroza-Gonzalez; G Jackson Snipes; Joyce O'Shaughnessy; Stephen Nishimura; Yong-Jun Liu; Virginia Pascual; Jacques Banchereau; Sangkon Oh; Karolina Palucka
Journal:  Cancer Immunol Res       Date:  2014-03-04       Impact factor: 11.151

6.  Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.

Authors:  Magali Terme; Mevyn Nizard; Cécile Badoual; Federico Sandoval; Michel-Francis Bureau; Ludovic Freyburger; Olivier Clement; Elie Marcheteau; Alain Gey; Guillaume Fraisse; Cécilia Bouguin; Nathalie Merillon; Estelle Dransart; Thi Tran; Françoise Quintin-Colonna; Gwennhael Autret; Marine Thiebaud; Muhammad Suleman; Sabine Riffault; Tzyy-Choou Wu; Odile Launay; Claire Danel; Julien Taieb; Jennifer Richardson; Laurence Zitvogel; Wolf H Fridman; Ludger Johannes; Eric Tartour
Journal:  Sci Transl Med       Date:  2013-02-13       Impact factor: 17.956

7.  Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer Vaccines.

Authors:  Mevyn Nizard; Hélène Roussel; Eric Tartour
Journal:  Clin Cancer Res       Date:  2015-11-05       Impact factor: 12.531

8.  Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Authors:  Timothy Murray; Silvia A Fuertes Marraco; Petra Baumgaertner; Natacha Bordry; Laurène Cagnon; Alena Donda; Pedro Romero; Grégory Verdeil; Daniel E Speiser
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

9.  Induction of resident memory T cells enhances the efficacy of cancer vaccine.

Authors:  Mevyn Nizard; Hélène Roussel; Mariana O Diniz; Soumaya Karaki; Thi Tran; Thibault Voron; Estelle Dransart; Federico Sandoval; Marc Riquet; Bastien Rance; Elie Marcheteau; Elizabeth Fabre; Marion Mandavit; Magali Terme; Charlotte Blanc; Jean-Baptiste Escudie; Laure Gibault; Françoise Le Pimpec Barthes; Clemence Granier; Luis C S Ferreira; Cecile Badoual; Ludger Johannes; Eric Tartour
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

10.  Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cells.

Authors:  Loane Decrausaz; Christelle Pythoud; Sonia Domingos-Pereira; Laurent Derré; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110
  10 in total
  7 in total

Review 1.  Therapeutic cancer vaccine: building the future from lessons of the past.

Authors:  T Tran; C Blanc; C Granier; A Saldmann; C Tanchot; Eric Tartour
Journal:  Semin Immunopathol       Date:  2018-07-05       Impact factor: 9.623

Review 2.  Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.

Authors:  Virgil Schijns; Alberto Fernández-Tejada; Žarko Barjaktarović; Ilias Bouzalas; Jens Brimnes; Sergey Chernysh; Sveinbjorn Gizurarson; Ihsan Gursel; Žiga Jakopin; Maria Lawrenz; Cristina Nativi; Stephane Paul; Gabriel Kristian Pedersen; Camillo Rosano; Ane Ruiz-de-Angulo; Bram Slütter; Aneesh Thakur; Dennis Christensen; Ed C Lavelle
Journal:  Immunol Rev       Date:  2020-06-28       Impact factor: 12.988

3.  Editorial: Tissue Resident Memory T Cells.

Authors:  Fathia Mami-Chouaib; Eric Tartour
Journal:  Front Immunol       Date:  2019-05-27       Impact factor: 7.561

Review 4.  Resident memory T cells, critical components in tumor immunology.

Authors:  Fathia Mami-Chouaib; Charlotte Blanc; Stéphanie Corgnac; Sophie Hans; Ines Malenica; Clémence Granier; Isabelle Tihy; Eric Tartour
Journal:  J Immunother Cancer       Date:  2018-09-04       Impact factor: 13.751

Review 5.  Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy.

Authors:  Nina Dumauthioz; Sara Labiano; Pedro Romero
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

6.  Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.

Authors:  C A Hartana; E Ahlén Bergman; A Broomé; S Berglund; M Johansson; F Alamdari; T Jakubczyk; Y Huge; F Aljabery; K Palmqvist; B Holmström; H Glise; K Riklund; A Sherif; O Winqvist
Journal:  Clin Exp Immunol       Date:  2018-08-24       Impact factor: 4.330

Review 7.  Metabolic Reprogramming and Longevity of Tissue-Resident Memory T Cells.

Authors:  Youdong Pan; Thomas S Kupper
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.